Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

HHS Conference on Pharmaceutical Costs and Pricing Practices - Agenda

HHS Conference on Pharmaceutical Pricing Practices, Utilization and Costs

August 8-9, 2000



Tuesday, August 8

8:00 am Registration/Refreshments

9:00 am Welcome, Conference Objectives and Structure

-- Margaret Hamburg, M.D., Assistant Secretary for Planning and Evaluation

-- Lawrence Bartlett, Ph.D., Conference Moderator

9:20 am Overview: Whats the Problem? A Synthesis of Research on Pharmaceutical Cost Pressures and Trends

This session will provide an overview of the components of the pharmaceutical market and the underlying cost drivers, and a brief synthesis of the research examining trends in pharmaceutical expenditures. This will be followed by a roundtable discussion of the issues by a panel of key stakeholders and policy experts.

12:00 Noon Lunch

1:15 pm Pricing Practices in the Pharmaceutical Market

This session will explore:

  • Factors influencing pricing decisions
  • Pricing at different levels of the distribution chain
  • Pricing practices across markets and purchasers
  • The potential impact of price transparency on pricing practices

5:00 pm Recess


Wednesday, August 9

8:45 am Recap of Day 1/Overview of Day 2

9:00 am Pharmaceutical Utilization Issues

This session will explore:

  • Factors contributing to increased utilization of pharmaceuticals
  • Assessing value what do we mean by appropriate drug use?
  • Trends in utilization, including trends by drug class

12:00 Noon Lunch

1:00 pm Strategies for Controlling Costs and Increasing Value from Pharmaceutical Expenditures

In this session, health care purchasers, PBMs, health plans, pharmacy representatives, policy experts, and other key stakeholders will share their experiences and insights concerning the strategies and tools that have been employed to control costs and increase the value realized from pharmaceutical expenditures.

3:45 pm Concluding Comments

4:00 pm Adjournment